Why Deepinder Goyal's Temple is drawing social media scrutiny

Zomato founder Deepinder Goyal’s wearable device has sparked a debate on social media. Critics, including medical professionals, have raised concerns about the product's marketing claims, specifically regarding its ability to measure brain blood flow and an unvalidated metric called Entropy. This scrutiny comes as the device is positioned as a wellness tool rather than a medical device.

For investors, this situation highlights the risks associated with high-profile endorsements and unproven health claims. While the wearable aims to tap into the growing health-tech market, the controversy could impact the company's reputation and consumer trust. The company's ability to address these concerns will be key to its future success in this sector.

Investors should monitor how Zomato handles the backlash and whether the device's efficacy is substantiated by credible research. The long-term impact on the brand's image and sales will depend on transparency and scientific validation.